CIK 0001651308
- Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981209416
- Phone
- +41 616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-02-08 | BAKER BROS. ADVISORS LP Director | Conversion · Series A-2 Preferred shares | −1,912,167 | 0 | ||
| 2016-02-08 | BAKER BROS. ADVISORS LP Director | Conversion · Series A-2 Preferred shares | −26,292,961 | 0 | ||
| 2016-02-08 | BAKER BROS. ADVISORS LP Director | Option exercise · Ordinary stock warrant (right to buy) | −238,850 | 0 | ||
| 2016-02-08 | BAKER BROS. ADVISORS LP Director | Option exercise · Ordinary stock warrant (right to buy) | −2,296,890 | 0 | ||
| 2016-02-08 | BAKER BROS. ADVISORS LP Director | Option exercise · Ordinary stock warrant (right to buy) | −56,853 | 0 | ||
| 2016-02-08 | OYLER JOHN CEO | Conversion | +9,398,380 | 59,780,349 | ||
| 2016-02-08 | OYLER JOHN CEO | Option exercise · Series A Warrant (Right to Buy) | −57,777 | 0 | ||
| 2016-02-08 | OYLER JOHN CEO | Option exercise · Series A Preferred Shares | +57,777 | 9,398,380 | ||
| 2016-02-08 | OYLER JOHN CEO | Conversion · Series A Preferred Shares | −9,398,380 | 0 | ||
| 2016-02-08 | Chen Timothy Yung-Cheng Director | Grant or award · Share Option (Right to Buy) | +460,626 | 460,626 | ||
| 2016-02-08 | Liang Howard CFO & Chief Strategy Officer | Purchase | +65,000 | $1.85 | $120K | 65,000 |
| 2016-02-08 | Yuan RuiRong Chief Medical Officer | Purchase | +130,000 | $1.85 | $241K | 130,000 |
| 2016-02-08 | CB Biotech Investment Ltd 10% owner | Conversion | +19,601,138 | 19,601,138 | ||
| 2016-02-08 | CB Biotech Investment Ltd 10% owner | Conversion · Series A Preferred Shares | −14,814,814 | 0 | ||
| 2016-02-08 | CB Biotech Investment Ltd 10% owner | Conversion · Series A-2 Preferred Shares | −4,786,324 | 0 |
Page 123 of 123 · 2,455 trades